|
|
| RAC December 4, 2003 - Presentation Materials |
|
| 94th Meeting Day 2 |
| Bethesda, Maryland |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
Discussion of Human Gene Transfer Protocol #0307-589 |
|
|
| |
A Phase 1 Study in Glaucoma Subjects Receiving SCH 412499 (rAd-p21) Administered as a Single Injection into the Subconjunctival Space Prior to Primary Trabeculectomy |
|
|
| |
Paul L. Kaufman, M.D., University of Wisconsin Medical School, Madison
Robert N. Weinreb, M.D., University of California, San Diego |
|
|
| |
Slides
|
|
| |
|
|
|
NIH Guidance on Informed Consent for Gene Transfer Research |
|
|
| |
Nancy M.P. King, J.D., University of North Carolina, Chapel Hill
Sue L. Levi-Pearl, Tourette's Syndrome Association, Inc., Bayside, NY |
|
|
| |
Slides
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0307-592 |
|
|
| |
A Phase 1 Study to Determine the Safety and Immunogenicity of Vaccination With Listeria Monocytogenes Expressing Human Papillomavirus Type 16 E7 for the Treatment of Progressive, Recurrent, and Advanced Squamous Cell Cancer of the Cervix |
|
|
| |
John Marshall, M.D., Georgetown University Medical Center, Washington, DC |
|
|
| |
Slides
|
|
| |
|
|
|
ADJOURN |
|
| |
|
Top of Page |
| |
|
|
|
|
